DK592585D0 - Fremgangsmaade til fremstilling af oxetanoner - Google Patents
Fremgangsmaade til fremstilling af oxetanonerInfo
- Publication number
- DK592585D0 DK592585D0 DK592585A DK592585A DK592585D0 DK 592585 D0 DK592585 D0 DK 592585D0 DK 592585 A DK592585 A DK 592585A DK 592585 A DK592585 A DK 592585A DK 592585 D0 DK592585 D0 DK 592585D0
- Authority
- DK
- Denmark
- Prior art keywords
- formula see
- see diagramm
- oxetanones
- manufacture
- procedure
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- -1 carbamoylmethyl Chemical group 0.000 abstract 3
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 abstract 2
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH610184 | 1984-12-21 | ||
| CH610184 | 1984-12-21 | ||
| CH406785 | 1985-09-19 | ||
| CH406785 | 1985-09-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK592585D0 true DK592585D0 (da) | 1985-12-19 |
| DK592585A DK592585A (da) | 1986-06-22 |
| DK168536B1 DK168536B1 (da) | 1994-04-18 |
Family
ID=25694557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK592585A DK168536B1 (da) | 1984-12-21 | 1985-12-19 | Fremgangsmåde til fremstilling af oxetanoner |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4983746A (da) |
| EP (1) | EP0189577B1 (da) |
| CN (1) | CN1010586B (da) |
| AT (1) | ATE48600T1 (da) |
| AU (1) | AU585555B2 (da) |
| CA (1) | CA1328881C (da) |
| DE (1) | DE3574700D1 (da) |
| DK (1) | DK168536B1 (da) |
| IE (1) | IE58917B1 (da) |
| NZ (1) | NZ214567A (da) |
| PH (1) | PH22445A (da) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
| CA1328881C (en) * | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
| CA2035972C (en) * | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
| US5260310A (en) * | 1990-02-26 | 1993-11-09 | Hoffmann-La Roche Inc. | Oxetanone compounds and pharmaceutical compositions containing them |
| PT1017408E (pt) * | 1997-02-05 | 2005-07-29 | Hoffmann La Roche | Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii |
| GB9727131D0 (en) | 1997-12-24 | 1998-02-25 | Knoll Ag | Therapeutic agents |
| CN1342169A (zh) * | 1999-10-29 | 2002-03-27 | 约翰·贾森·金特里·穆林斯 | 氧杂环丁烷酮衍生物 |
| EP1132389A1 (en) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
| EP1307263B1 (en) * | 2000-07-28 | 2005-04-20 | F. Hoffmann-La Roche Ag | New use of lipase inhibitors |
| KR100494245B1 (ko) | 2000-08-09 | 2005-06-13 | 에프. 호프만-라 로슈 아게 | 리파제 억제제의 용도 |
| US6900226B2 (en) | 2000-09-06 | 2005-05-31 | Hoffman-La Roche Inc. | Neuropeptide Y antagonists |
| AU2167002A (en) | 2000-10-16 | 2002-06-11 | Hoffmann La Roche | Indoline derivatives and their use as 5-ht2 receptor ligands |
| GB0030710D0 (en) | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
| KR100539143B1 (ko) | 2000-12-27 | 2005-12-26 | 에프. 호프만-라 로슈 아게 | 인돌 유도체 및 그의 5-ｈｔ2ｂ 및 5-ｈｔ2ｃ 수용체리간드로서의 용도 |
| GB0106177D0 (en) | 2001-03-13 | 2001-05-02 | Hoffmann La Roche | Piperazine derivatives |
| JP3715280B2 (ja) | 2001-05-21 | 2005-11-09 | エフ．ホフマン−ラ ロシュ アーゲー | ニューロペプチドｙレセプターのリガンドとしてのキノリン誘導体 |
| US20030027786A1 (en) | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
| US6730319B2 (en) | 2001-06-06 | 2004-05-04 | Hoffmann-La Roche Inc. | Pharmaceutical compositions having depressed melting points |
| US6787558B2 (en) | 2001-09-28 | 2004-09-07 | Hoffmann-La Roche Inc. | Quinoline derivatives |
| EP1470116A4 (en) | 2001-12-04 | 2005-04-06 | Biogal Gyogyszergyar | PREPARATION OF THE ORLISTAT AND CRYSTALLINE FORMS OF THE ORLISTAT |
| GB0202015D0 (en) | 2002-01-29 | 2002-03-13 | Hoffmann La Roche | Piperazine Derivatives |
| WO2003066055A1 (en) | 2002-02-04 | 2003-08-14 | F. Hoffmann-La Roche Ag | Quinoline derivatives as npy antagonists |
| MXPA04008379A (es) | 2002-02-28 | 2004-11-26 | Hoffmann La Roche | Derivados de tiazol como antagonistas del receptor de neuropeptido y (npy). |
| AU2003226370A1 (en) * | 2002-04-17 | 2003-11-03 | The Burnham Institute | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation |
| US7728153B2 (en) | 2002-04-17 | 2010-06-01 | The Burnham Institute For Medical Research | Method for the asymmetric synthesis of beta-lactone compounds |
| EP1560816A1 (en) | 2002-07-05 | 2005-08-10 | F. Hoffmann-La Roche Ag | Quinazoline derivatives |
| RU2324685C2 (ru) | 2002-08-07 | 2008-05-20 | Ф.Хоффманн-Ля Рош Аг | Производные тиазола, способ их получения и применение, фармацевтическая композиция, обладающая свойствами антагонистов рецепторов npy |
| RU2296759C2 (ru) | 2002-09-12 | 2007-04-10 | Ф.Хоффманн-Ля Рош Аг | N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты) |
| RU2315767C2 (ru) | 2002-11-25 | 2008-01-27 | Ф.Хоффманн-Ля Рош Аг | Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний |
| JPWO2004065346A1 (ja) * | 2003-01-21 | 2006-05-18 | 住友化学株式会社 | （−）−テトラヒドロリプスタチンおよびその中間体の製造方法 |
| EP1457206A1 (en) * | 2003-03-13 | 2004-09-15 | Fournier Laboratories Ireland Limited | Combined use of a fibrate and orlistat for the treatment of obesity |
| WO2004113314A1 (en) * | 2003-06-23 | 2004-12-29 | Biocon Limited | Novel boronate esters |
| GB0314967D0 (en) | 2003-06-26 | 2003-07-30 | Hoffmann La Roche | Piperazine derivatives |
| EP1651627A2 (en) * | 2003-07-15 | 2006-05-03 | Ranbaxy Laboratories Limited | Process for preparation of oxetan-2-ones |
| RU2006107444A (ru) | 2003-08-12 | 2007-09-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | 2-амино-5-бензоилтиазолы в качестве антагонистов npy |
| RU2321586C2 (ru) | 2003-08-12 | 2008-04-10 | Ф.Хоффманн-Ля Рош Аг | Производные тиазола в качестве антагонистов npy |
| CN101171252B (zh) | 2005-05-03 | 2011-06-01 | 霍夫曼-拉罗奇有限公司 | 作为5-ht2配体的四环氮杂吡嗪并二氢吲哚类化合物 |
| AU2006281435A1 (en) | 2005-08-18 | 2007-02-22 | F. Hoffmann-La Roche Ag | Thiazolyl piperidine derivatives useful as H3 receptor modulators |
| US20090171104A1 (en) * | 2005-10-05 | 2009-07-02 | Killol Patel | Process for the preparation of orlistat |
| ES2359739T3 (es) | 2005-11-30 | 2011-05-26 | F. Hoffmann-La Roche Ag | Derivados de indol-2-il-amida 1,5-sustituida. |
| CN101316835A (zh) | 2005-11-30 | 2008-12-03 | 霍夫曼-拉罗奇有限公司 | 5-取代的吲哚-2-甲酰胺衍生物 |
| CN101316838B (zh) | 2005-11-30 | 2013-01-30 | 霍夫曼-拉罗奇有限公司 | 用作h3调节剂的1,1-二氧代-硫代吗啉基吲哚基甲酮衍生物 |
| DE602006010433D1 (de) | 2005-12-09 | 2009-12-24 | Hoffmann La Roche | Für die behandlung von obesitas geeignete tricyclische amidderivate |
| KR20080068127A (ko) | 2005-12-15 | 2008-07-22 | 에프. 호프만-라 로슈 아게 | 피롤로[2,3-ｃ]피리딘 유도체 |
| ES2344077T3 (es) | 2005-12-16 | 2010-08-17 | F.Hoffmann-La Roche Ag | Derivados de pirrolo(2,3-b)piridina como moduladores del receptor h3. |
| RU2008132966A (ru) * | 2006-01-13 | 2010-02-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные циклогексилпиперазинилметанона и их применение в качестве модуляторов гистамин н3 рецептора |
| CA2637449A1 (en) * | 2006-01-23 | 2007-07-26 | F. Hoffmann-La Roche Ag | Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| US7432255B2 (en) | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
| EP2032554A1 (en) | 2006-05-30 | 2009-03-11 | F. Hoffmann-Roche AG | Piperidinyl pyrimidine derivatives |
| US7514433B2 (en) | 2006-08-03 | 2009-04-07 | Hoffmann-La Roche Inc. | 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| US20080146559A1 (en) | 2006-12-08 | 2008-06-19 | Li Chen | 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives |
| SG182171A1 (en) * | 2007-06-06 | 2012-07-30 | Ranbaxy Lab Ltd | Process for the preparation of orlistat |
| BRPI0814532A2 (pt) | 2007-07-25 | 2015-01-27 | Hoffmann La Roche | Compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação dos receptores de h3, e uso desses compostos para a preparação de medicamentos. |
| KR101076680B1 (ko) * | 2007-11-01 | 2011-10-26 | 한미홀딩스 주식회사 | (6ｒ)-3-헥실-4-히드록시-6-운데실-5,6-다이히드로피란-2-온의 제조방법 및 이에 사용되는 중간체 |
| CN105384636B (zh) * | 2015-11-17 | 2017-12-26 | 湖南尔康制药股份有限公司 | 一种柠檬酸酯的制备方法 |
| CN118955554B (zh) * | 2024-10-15 | 2025-08-29 | 浙江瑞博制药有限公司 | 一种取代氧杂环化合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2023604B (en) * | 1978-05-25 | 1982-07-28 | Microbial Chem Res Found | Physiologically active derivatives of esterastin and production thereof |
| CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
| CA1270837A (en) * | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
| CA1328881C (en) * | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
-
1985
- 1985-11-19 CA CA000495616A patent/CA1328881C/en not_active Expired - Lifetime
- 1985-12-16 CN CN85109209A patent/CN1010586B/zh not_active Expired
- 1985-12-16 NZ NZ214567A patent/NZ214567A/en unknown
- 1985-12-16 AU AU51258/85A patent/AU585555B2/en not_active Expired
- 1985-12-17 EP EP85116098A patent/EP0189577B1/de not_active Expired
- 1985-12-17 PH PH33206A patent/PH22445A/en unknown
- 1985-12-17 DE DE8585116098T patent/DE3574700D1/de not_active Expired - Lifetime
- 1985-12-17 AT AT85116098T patent/ATE48600T1/de not_active IP Right Cessation
- 1985-12-19 DK DK592585A patent/DK168536B1/da not_active IP Right Cessation
- 1985-12-20 IE IE327685A patent/IE58917B1/en not_active IP Right Cessation
-
1989
- 1989-08-08 US US07/391,732 patent/US4983746A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IE58917B1 (en) | 1993-12-01 |
| EP0189577B1 (de) | 1989-12-13 |
| NZ214567A (en) | 1990-01-29 |
| PH22445A (en) | 1988-09-12 |
| CN85109209A (zh) | 1986-09-17 |
| DK592585A (da) | 1986-06-22 |
| EP0189577A2 (de) | 1986-08-06 |
| US4983746A (en) | 1991-01-08 |
| EP0189577A3 (en) | 1987-05-06 |
| DE3574700D1 (de) | 1990-01-18 |
| CA1328881C (en) | 1994-04-26 |
| DK168536B1 (da) | 1994-04-18 |
| IE853276L (en) | 1986-06-21 |
| ATE48600T1 (de) | 1989-12-15 |
| AU5125885A (en) | 1986-06-26 |
| AU585555B2 (en) | 1989-06-22 |
| CN1010586B (zh) | 1990-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK592585D0 (da) | Fremgangsmaade til fremstilling af oxetanoner | |
| SE7506292L (sv) | N-substituerade-14-hydroxi-3-substituerade-morfinanderivat och forfarande for framstellning derav | |
| ATE54938T1 (de) | Verfahren zur reinigung des japanischen enzephalitisvirus. | |
| GB1393545A (en) | Unsaturated phosphate esters useful in forming coatings | |
| DK630988A (da) | Fremgangsmaade til fremstilling af delta1,4-3-keto-21-hemiester-steroider | |
| BR8000385A (pt) | Processo de purificacao de um acido fosforico impuro | |
| AU7674881A (en) | Hydroxycyanomethylphosphonic acid | |
| ATE1142T1 (de) | Verfahren zur herstellung von methylen-bis-(4-phenyl-carbaminsaeureester). | |
| SE7601948L (sv) | Sett att framstella karboxi-alkan-fosfonsyror och karboxi-alkyl-fosfinsyror | |
| GB2012756A (en) | Preparation of 5-arylhydantoins | |
| ES8307236A1 (es) | Un procedimiento para la preparacion de ranitidina. | |
| SE8002295L (sv) | Forbettrat forfarande for framstellning av 3-0-demetylfortimiciner | |
| ATE9477T1 (de) | Verfahren zur herstellung von 1,1'-diacetalen. | |
| SE7903828L (sv) | 1,6-dimesyl-3,4-dimetyl-d-mannitol jemte sett for dess framstellning | |
| JPS5212129A (en) | Process for preparation of fluorocarbonvinylether | |
| OA05048A (fr) | Procédé de purification de l'acide phosphorique. | |
| DK354883A (da) | Fremgangsmaade til inversion af konfigurationen hos optisk aktive forbindelser samt optisk aktive mellemprodukter ved denne fremgangsmaade | |
| DK497483D0 (da) | Fremgangsmade og mellemprodukter til fremstilling af 1,1-dioxopenicillanoyloxymethyl-6-beta-aminopenicillanat | |
| DK159432C (da) | Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater | |
| ES481479A1 (es) | Procedimiento para la preparacion de esteres dialcohilicos de acidos n-ciano-ditioimidocarbonicos. | |
| JPS56169664A (en) | Preparation of nitrile | |
| UA6043A1 (uk) | Спосіб одержання похідних хлорамбуціла /його варіанти/ | |
| ES8303315A1 (es) | "procedimiento para la preparacion de 4-metilmercapto-2-acetoxi-butiraldehido". | |
| DK98792A (da) | Fremgangsmaade til fremstilling af oxetanoner | |
| BR7906203A (pt) | Processo de obtencao de um acido fosforico purificado |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment | ||
| AHS | Application shelved for other reasons than non-payment | ||
| B1 | Patent granted (law 1993) | ||
| PUP | Patent expired |